Hemogenyx Pharmaceuticals Share Discussion Threads

[andrbea] 11/12/2017 13:39

up 7% today

[the stigologist] 10/12/2017 19:31

Over-valued p.o.s

[moneytree1] 07/12/2017 08:28

LakePharma, the largest US-based biologics contract research organisation, brings integrated antibody engineering and bioproduction expertise to allow Hemogenyx to advance its CDX product through the necessary preclinical stages to potentially be ready to enter the clinic within 16 months. To date, work is progressing successfully toward the Company's immediate goal of submitting an IND application to the US Food and Drug Administration

University of Oxford....

very happy to stay in this space for a while.gl

[rathean] 05/12/2017 10:09

Back in again, chart suggests retesting earlier low. Hopefully see a nice bounce back :)

[moneytree1] 04/12/2017 22:33

it could be an idea to buy all these prices.gl

[maverick247] 04/12/2017 21:36

Bought in today while its quiet and under radar!

[loveandmoney1] 01/12/2017 08:35

does anyone know how original SILF shareholders get their warrants?or confirmation of them?

[fullbright] 23/11/2017 17:14

So who have we got here on the BB. Just thought I'd break the ice so to speak.

[purple11] 21/11/2017 08:08

xletitmove@round



12 26

[krowelet] 20/11/2017 22:52

Good article that blueball, thanks. Plenty of news flow to come should get this potentially great little company moving in terms of sp,, currently below the reverse takeover and fundraising price of 3.5p

[adejuk] 20/11/2017 12:33

i believe this will be a blockbuster but i sold my 100k today.
i'm well into my 70's now and i guess it could take 8 years to get to market.
gla.

[blueball] 20/11/2017 08:12

Not hanging about are they.

[purple11] 20/11/2017 07:53

xXTiPSXHEETSXx

BUY HOLD ADD

[purple11] 20/11/2017 07:24

Dr. Vladislav Sandler, CEO of Hemogenyx, said: "The collaboration between Hemogenyx and the University of Oxford promises to completely transform the treatment of blood cancers and turbo-charge the development of Hemogenyx's Hu-PHEC technologies. By pairing Oxford's established science and know-how with Hemogenyx's advanced technologies, we are moving closer to developing reliable products that will eventually save lives."

Professor Jagdeep Nanchahal at the University of Oxford, who is leading the Oxford team in the collaboration with Hemogenyx, said: "I'm excited to be partnering with Hemogenyx on their ground-breaking medical research. The in-vivo tests Hemogenyx is about to conduct have the potential to improve stem cell engraftment for patients suffering from blood cancers."

[blueball] 14/11/2017 18:25

Latest interview with Alan Green starts at 20 mins.

[garfield8] 14/11/2017 10:43

Big news very soon

[fillipe] 14/11/2017 08:55

AGM is Thursday 7 Dec, London.

f

[ny boy] 14/11/2017 08:42

I have been accumulating whilst cheap and under the radar, see you at 10p+. next year

[wossupsa] 14/11/2017 07:41

Way to early for that bs bluebell, will check in every couple of months but low expectations for next year or so.